integrated diagnostics and patient selection for active surveillance and treatment
Published 4 months ago • 116 plays • Length 1:58Download video MP4
Download video MP3
Similar videos
-
24:42
a radiation oncologist's approach to active surveillance and our role in local therapy
-
23:37
active surveillance who is the right patient and what is the right protocol
-
20:44
active surveillance 2021 (part 3) - patient selection, monitoring, and innocuous interventions
-
12:19
active surveillance 2022: who qualifies, who does not and how should it be monitored
-
20:50
active surveillance 2021 - from bench to bedside
-
25:24
active surveillance in 2021 part 2: imaging and biomarkers
-
24:04
active surveillance or focal therapy as primary management
-
20:23
active surveillance criteria and follow-up protocol
-
11:04
radiogenomics in active surveillance how can we integrate mpmri and genomics to monitor pca
-
29:23
how should we monitor patients during surveillance?
-
9:02
focal therapy for localized pca: is there a middle ground between active surveillance and treatment
-
11:13
active surveillance in favorable intermediate-risk prostate cancer
-
13:06
selecting candidates for focal therapy
-
12:46
what role do markers play in establishing active surveillance or definitive care?
-
20:39
active surveillance or: shrinking the gray zone
-
10:06
imaging tools for improving risk assessment, selection of patients for biopsy, and tissue sampling
-
24:40
guidelines based management of localized and locally advanced rcc
-
54:39
urowebinar: mri and active surveillance in prostate cancer
-
31:48
navigating prostate cancer: active surveillance and advanced imaging insights